Scott C. Morgan

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 536 citations · Full text

Medicine, Oncology, Radiation Oncology +17

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 424 citations

Medicine, Oncology, Surgery +17

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Ronald C. Chen, R. Bryan Rumble, D.A. Loblaw et al. · Journal of Clinical Oncology · 2016 · 362 citations · Full text

Medicine, Oncology, Urology +10

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 303 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline

Scott C. Morgan, Karen E. Hoffman, D.A. Loblaw et al. · Practical Radiation Oncology · 2018 · 237 citations · Full text

Medicine, Radiation Oncology, Urology +16